Domany Y., Shelton R.C. and McCullumsmith C.B. (in press). Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial. Depression and Anxiety.

Allen L. and Dwivedi Y. (in press). MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior. Molecular Psychiatry

Jose O. Maximo, Eric A. Nelson, William P. Armstrong, Nina V. Kraguljac, & Adrienne C. Lahti. (in press). Duration of Untreated Psychosis Correlates with Brain Connectivity and Morphology in Medication-Naïve Patients with First Episode Psychosis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.

Birur B., Kraguljac N.V., VerHoef L.W., Jindal R.D., Reid M.A., Luker A., Lahti A.C. (in press). Neurometabolic correlates of six and sixteen weeks of treatment with risperidone in medication-naïve first episode psychosis patients. Translational Psychiatry.

Nelson E.A., Kraguljac N.V., White D.M., Jindal R.D., Shin A.L., Lahti A.C. (in press) A prospective longitudinal investigation of cortical thickness and gyrification in schizophrenia. Canadian Journal of Psychiatry.